Suzhou
China
Soochow University, Department of Pharmacy
COVID-19, SARS-CoV-2, male patients, androgen receptor, antagonist, proxilutamide, ACE-2, TMPRSS2, Macrophage activation
almonertinib, anlotinib, TKI, LC-MS/MS,
tyrosine kinase inhibitors, LC-MS/MS, therapeutic drug monitoring